Skip Ribbon Commands
Skip to main content
Menu

Dr Chong Jun Hua

Dr Chong Jun Hua from National Heart Centre Singapore

Dr Chong Jun Hua

B. Med., FRACP, Cardiology

Associate Consultant

National Heart Centre Singapore

Specialty: Cardiology

Sub-specialties: Cardio-Oncology

Clinical Appointments

  • Associate Consultant Department of Cardiology National Heart Centre SingaporeNational Heart Centre Singapore

Profile

Dr Chong Jun Hua is an Associate Consultant from the Department of Cardiology at National Heart Centre Singapore.

She has received Cardiology training at the Royal Prince Alfred Hospital (Sydney), The Alfred Hospital (Melbourne) and Nepean Hospital (Sydney) and has completed a Fellowship in multimodality cardiac imaging (CMR/ECHO/CT) and Cardio-Oncology at Barts Heart Centre, London.

Dr Chong’s subspecialty clinical interests are in multimodality cardiac imaging and Cardio-oncology and is also actively involved in ongoing research trials on the application of multimodality cardiac imaging to improve cardiovascular outcomes and cardioprotective strategies in Cardio-oncology.

She is currently also pursuing a PhD in Clinical Sciences at Duke-NUS Medical School in Cardiovascular Medicine.

Education

  • Bachelor of Medicine (Australia)
  • Fellow of the Royal Australasian College of Physicians (FRACP, Cardiology)

Professional Appointments and Committee Memberships

  • Associate Consultant, Department of Cardiology, National Heart Centre Singapore, 2019 – Present
  • Clinical Instuctor, Duke-NUS Medical School, June 2020 – Present
  • PhD student in Clinical Sciences, Duke-NUS Medical School
  • Member of European Association of Cardiovascular Imaging, 2017 – Present
  • Member of the Global Science and Technology Forum, 2014
  • Singapore Medical Council Specialist Accreditation Board Medical Registration, 2019 – Present 
  • Australian Health Practitioner Regulation Agency General and Specialist Medical Registration, 2010 – Present
  • General Medical Council United Kingdom Medical Registration, 2017 – Present 

Awards

  • National Medical Research Council Research Training Fellowship: November 2019 – November 2022
  • National Medical Research Council CCG- SEED Grant: October 2019 – October 2020
  • First Runner-up in Best Cases around the World category at EuroCMR Congress 2019
  • Winner of “Best Research Paper” award at the 2nd Annual Cardiology and Cardiovascular Medicine Conference, Singapore December 2014, hosted by the Global Science and Technology Forum

Research Interests

  • Improving acute myocardial infarction outcomes through pharmacological interventions and telemedicine strategies.
  • Cardioprotection in Cardio-Oncology: Disease mechanisms and therapeutic options.
  • The use of multimodality cardiac imaging techniques to improve understanding and treatment of cardiovascular diseases.

Publications

  • A review of 5-fluorouracil cardiotoxicity: Proposed pathophysiology, presentation, potential interventions. Jun Chong and AK Ghosh. Interventional Cardiology Review, May 2019, Volume 14(2), Page 89-94 
  • Remote ischemic conditioning in ST-segment elevation myocardial infarction: an update. Jun Chong, Heerajnarain Bulluck, En Ping Yap, Andrew F.W. Ho, William A. Boisvert, Derek J. Hausenloy. Conditioning Medicine, August 2018, Volume 1, Issue 5 
  • Clozapine-induced reversible Brugada Syndrome. Jun Chong and F. Eversheim GSTF Journal of Advances in Medical Research Oct 2015, Volume 1, No. 3, Page 18-20
  • Chronic remote ischemic conditioning for cardiovascular protection. Jun Chong, H. Bulluck, AFW. Ho, W.A. Boisvert, DJ Hausenloy. Conditioning Medicine, 2019, 2(4). 164-169.
  • Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm? Jun Chong, AFW. Ho, J. Yap, H. Bulluck, DJ. Hausenloy. Accepted for publication in Conditioning Medicine, Oct 2019 issue.
  • Remote ischemic conditioning in Emergency Medicine – clinical frontiers and research opportunities. AFW. Ho, Jun Chong, MEH. Ong, DJ. Hausenloy. Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches. April 2019.

Research Trials

  • Platelet Inhibition to Target Reperfusion Injury (PITRI trial)
  • Platelet STEMI study: To investigate the effects of high blood glucose at time of STEMI admission on platelet activation and coronary microvascular injury.
  • Improving reModelling in Acute myoCardial infarction Using Live and Asynchronous Telemedicine (IMMACULATE trial)
  • Post-Acute Myocardial Infarction Left ventricular remodeling biomarker Analysis (PAMILA trial)
  • Metabolic Imaging to Detect Anthracycline Cardiomyopathy (MIDAC) study
  • Optimizing cardiac care in cancer patients study
  • Optimising the protocol for remote ischaemic conditioning (RIC): the RIC Protocol study
  • Electroacupuncture for heart protection: clinical application in patients undergoing cardiac bypass surgery